Your browser doesn't support javascript.
loading
Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib.
Coltro, Giacomo; Capecchi, Giulio; Maffioli, Margherita; Mannelli, Francesco; Mora, Barbara; Atanasio, Alessandro; Iurlo, Alessandra; Maccari, Chiara; Farina, Mirko; Nacca, Elena; Caramella, Marianna; Signori, Leonardo; Borella, Miriam; Bertù, Lorenza; Esposito, Maria; Guglielmelli, Paola; Passamonti, Francesco; Vannucchi, Alessandro Maria.
Afiliação
  • Coltro G; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence.
  • Capecchi G; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence.
  • Maffioli M; Hematology Unit, ASST Sette Laghi, Ospedale di Circolo, Varese.
  • Mannelli F; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence.
  • Mora B; Hematology Division, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan.
  • Atanasio A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence.
  • Iurlo A; Hematology Division, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan.
  • Maccari C; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence.
  • Farina M; Hematology Unit, ASST Spedali Civili di Brescia, Brescia.
  • Nacca E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence.
  • Caramella M; Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan.
  • Signori L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence.
  • Borella M; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence.
  • Bertù L; Department of Medicine and Surgery, University of Insubria, Varese.
  • Esposito M; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence.
  • Guglielmelli P; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence.
  • Passamonti F; Hematology Division, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan.
  • Vannucchi AM; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence. a.vannucchi@unifi.it.
Haematologica ; 109(10): 3398-3403, 2024 Oct 01.
Article em En | MEDLINE | ID: mdl-38813708

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Nitrilas Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article País de publicação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Nitrilas Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article País de publicação: Itália